Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Robert Keith Warner is Director at Rxsight. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 18, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
As of the latest filing on , Robert Keith Warner reported holding 78,076 shares of Rxsight (RXST), worth about $415K at the last close of $5 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Rxsight RXST | 78,076 | 78K direct | $5 | $415K | Jun 17, 2026 |
Is this Robert Keith Warner’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
RxsightRXST
Jun 17, 202637Kdisclosed Jun 18
DetailsOfficial recordRobert Keith Warner bought shares on the open market in 2021, and has not bought since 2021. Sales in 2 of the 6 years since 2021.
Robert Keith Warner reported 1 open-market purchase and 4 sales since 2021; purchases in 2021.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $1.01M2×2 trades |
| 2023 | — | $701K2×2 trades |
| 2021 | $700K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Jun 17, 2026, Robert Keith Warner reported holding 78,076 shares of Rxsight (RXST). At the last close of $5 on Nov 13, 2026, that is about $415K. This is the stake disclosed in filings, not a net worth.
Robert Keith Warner bought shares on the open market in 2021, and has not bought since 2021. Sales in 2 of the 6 years since 2021.
In SEC filings since 2021: the latest open-market purchase is from 2021; the latest open-market sale is from 2024.
Rxsight (RXST), from 2021 to 2024: 1 purchase and 4 sales.
Robert Keith Warner reported 1 open-market purchase and 4 sales here, 2021 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.